Coming tomorrow, details about a feature that will let you test
our results by rating the papers directly yourself.
Not exact matches
Important factors that could cause actual
results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build
rates of certain aircraft; 6) the effect on aircraft demand and build
rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a
result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange
rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment
by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft
resulting from cancellations, deferrals, or reduced orders
by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount
rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit
ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending
by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest
rates increase substantially; 27) the effectiveness of any interest
rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a
result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange
rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
These amounts are derived
by translating current year
results at prior year average exchange
rates.
We all do it — routinely sort through search
results by customer star
ratings and scroll through buyer feedback before making a final shopping decision.
This has
resulted in decreased sales costs and marketing spend and some businesses have reported lead conversion
rates improving
by up to 300 %.
Rather than the Fed pursuing a policy
resulting in some steady
rate of growth in the money supply, I would suggest that the Fed attempt to produce a steady
rate of growth in the sum of the credit it creates and the credit created
by depository institutions, i.e., commercial banks, savings associations and credit unions.
Today's
rate reflects what has been the longest deviation from historical norms, and as a
result, today's market consumption and demand has been pulled forward
by a generation.
These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted
by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the
results of our clinical development activities may not be positive, or predictive of real - world
results or of
results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment
rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization
by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made
by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
Even though our activities are likely to
result in a lower national debt over the long term, I sometimes hear the complaint that the Federal Reserve is enabling bad fiscal policy
by keeping interest
rates very low and thereby making it cheaper for the federal government to borrow.
«A decrease in nominal GDP growth
resulting solely from a one - year, 1 - percentage - point decrease in the
rate of GDP inflation» reduces the budgetary balance
by $ 1.9 billion.
The
results were conclusive: A blue CTA increased the conversion
rate by 20 percent.
They often suffer from both mental and physical health problems at a higher
rate than workers in other industries as a
result of their working conditions, which include operating under hard - nosed management practices and getting yelled at all day
by irate customers.
Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest
rates and foreign currency exchange
rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred
by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange
rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may
result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered
by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
The Healthcare Reform Law, including The Patient Protection and Affordable Care Act and The Healthcare and Education Reconciliation Act of 2010, could have a material adverse effect on Humana's
results of operations, including restricting revenue, enrollment and premium growth in certain products and market segments, restricting the company's ability to expand into new markets, increasing the company's medical and operating costs
by, among other things, requiring a minimum benefit ratio on insured products, lowering the company's Medicare payment
rates and increasing the company's expenses associated with a non-deductible health insurance industry fee and other assessments; the company's financial position, including the company's ability to maintain the value of its goodwill; and the company's cash flows.
In addition to the factors impacting the year - over-year changes in quarterly GAAP pretax income, GAAP EPS for 1Q18 was further affected
by a lower number of shares primarily reflecting share repurchases in 2017 and the impact of a lower tax
rate in 1Q18
resulting from the Tax Reform Law.
This will
result in exorbitant combined personal / corporate tax
rates on dividends and capital gains earned
by individual business owners.
A 2013 analysis of the Senate's immigration reform bill
by the nonpartisan Congressional Budget Office estimates its passage would have
resulted in nine million more people entering the U.S. work force in the next 20 years, with new immigrants participating at a higher
rate, on average, than other U.S. residents.
In addition, both variable and fixed -
rate mortgage
rates have risen over the past year as a
result of moves
by the Bank of Canada and fluctuations in the bond markets.
Among the factors that could cause actual
results to differ materially are the following: (1) worldwide economic, political, and capital markets conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) the Company's credit
ratings and its cost of capital; (3) competitive conditions and customer preferences; (4) foreign currency exchange
rates and fluctuations in those
rates; (5) the timing and market acceptance of new product offerings; (6) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused
by natural and other disasters and other events); (7) the impact of acquisitions, strategic alliances, divestitures, and other unusual events
resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements than estimated; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (11) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10 - K for the year ended Dec. 31, 2017, and any subsequent quarterly reports on Form 10 - Q (the «Reports»).
As a
result, the implied probability of 4 (or greater)
rate hikes in 2016 (as predicted
by the dot plot) dropped from 4.7 % on Wednesday to under 1 % on Friday.
System - wide sales growth and comparable sales are measured on a constant currency basis, which means that
results exclude the effect of foreign currency translation and are calculated
by translating prior year
results at current year monthly average exchange
rates.
Chinese dairy production and consumption has soared in the past three decades, averaging a 12.8 % annual growth
rate since 2000 as a
result of changing diet trends that are shifting more toward Western foods, according to a report
by the Institute of Agriculture and Trade Policy.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial
results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven
by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused
by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable
results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held
by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange
rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
First quarter
results were helped
by a lower income tax
rate, and J.P. Morgan also adopted new accounting guidance on revenue recognition.
Even as competitors, you can both benefit either
by ordering in greater quantity, which will be a bigger order for the supplier and may also
result in better
rates from the supplier as a means of saying thank you for the referral.
Borrowers should keep in mind that lower interest
rates at the beginning of a loan
result in more actual savings than lower interest
rates towards the end of a loan since the principal is lower as time goes
by (interest charged is a percentage of the current loan balance).
Actual
results could differ materially from those expressed in or implied
by the forward - looking statements contained in this release because of a variety of factors, including conditions to, or changes in the timing of, proposed real estate and other transactions, prevailing interest
rates and non-recurring charges, store closings, competitive pressures from specialty stores, general merchandise stores, off - price and discount stores, manufacturers» outlets, the Internet, mail - order catalogs and television shopping and general consumer spending levels, including the impact of the availability and level of consumer debt, the effect of weather and other factors identified in documents filed
by the company with the Securities and Exchange Commission.
«The
results include improvements in heart
rates and increased productivity, and help Aetna reduce its employee health benefit costs
by 7 percent in 2012,» Aetna CEO Mark Bertolini told The Huffington Post.
If expectations are forward - looking, and if economic agents think some part of the debt will have to be paid for
by printing money, higher interest
rates might be the
result, or higher wages.
«This issuance reflects OnDeck's most successful securitization issuance to date, with strong investor interest
resulting in broad participation
by existing and new institutional investors, expected improvement in credit
ratings, and a significant reduction in cost of funds despite a rising interest
rate environment, and is a testament to the strength of OnDeck's business model.»
The
result in the early 1980s when debt - leveraged buyouts really gained momentum was that financial investors were able to obtain twice as high a return (at a 50 % corporate income tax
rate)
by debt financing as they could get
by equity financing.
To the extent there is «co-ordination» it will be accidental, as a
result of similar activities
by various countries directed towards managing exchange
rates against the US dollar — with an eye, of course, on what their neighbours are doing.
Google testing filter buttons for Shopping ads: Filter
by local availability, top
rated and more In more news from Google, Search Engine Land says: «Google has started testing product filter buttons for product listing ads in the search
results, including a special «In Store» filter for Local Inventory Ads.
He addressed this problem a bit
by lowering the bottom
rate to 10 percent from 12 percent in the campaign plan, but it's still likely that a Trump proposal that includes these elements will
result in a tax increase for millions of middle - class people, and the lower standard deduction doesn't help:
To get more accurate and personalized
results, please proceed
by selecting «Apply Now» or «
Rate Quote.»
The
result: Australia's firearm homicide
rate dropped
by about 42 percent in the seven years after the law passed, and its firearm suicide
rate fell
by 57 percent, according to a review of the evidence
by Harvard researchers.
Graph 8 shows the net
result of the linkage: a 1 per cent increase in the real cash
rate, lasting for two years, would raise the exchange
rate by around 3 per cent and would trim 0.3 per cent off inflation, with a lag which reaches its peak effect in ten quarters.
«The central bank, if necessary, is fully capable of stabilising the exchange
rate through direct intervention in the foreign exchange market to avoid [the] herd mentality
resulting in irrational movements of the
rate,» Ma was quoted as saying
by the official Xinhua news agency.
Factors that could cause actual
results to differ include general business and economic conditions and the state of the solar industry; governmental support for the deployment of solar power; future available supplies of high - purity silicon; demand for end - use products
by consumers and inventory levels of such products in the supply chain; changes in demand from significant customers; changes in demand from major markets such as Japan, the U.S., India and China; changes in customer order patterns; changes in product mix; capacity utilization; level of competition; pricing pressure and declines in average selling prices; delays in new product introduction; delays in utility - scale project approval process; delays in utility - scale project construction; delays in the completion of project sales; continued success in technological innovations and delivery of products with the features customers demand; shortage in supply of materials or capacity requirements; availability of financing; exchange
rate fluctuations; litigation and other risks as described in the Company's SEC filings, including its annual report on Form 20 - F filed on April 27, 2017.
Factors that could cause actual
results to differ include general business and economic conditions and the state of the solar industry; governmental support for the deployment of solar power; future available supplies of high - purity silicon; demand for end - use products
by consumers and inventory levels of such products in the supply chain; changes in demand from significant customers; changes in demand from major markets such as Japan, the U.S., India and China; changes in customer order patterns; changes in product mix; capacity utilization; level of competition; pricing pressure and declines in average selling prices; delays in new product introduction; delays in utility - scale project approval process; delays in utility - scale project construction; continued success in technological innovations and delivery of products with the features customers demand; shortage in supply of materials or capacity requirements; availability of financing; exchange
rate fluctuations; litigation and other risks as described in the Company's SEC filings, including its annual report on Form 20 - F filed on April 20, 2016.
The FAA did do an audit in 2016 and it defends its record saying: The FAA «s oversight has produced
results and the
rate of incidents reported
by Allegiant to the FAA «s air traffic organization trended downward in recent years.
As a
result there was actually a relatively low
rate of client redemptions, especially relative to the tech bubble of 2000, and importantly, clients participated in the subsequent increase in the value of their investment portfolios
by staying invested as markets recovered.
Combining this with poor sales growth
results in a dismal outlook for earnings 3) the pressure on earnings will continue to hurt capital spending, which is usually just a magnified image of earnings, 4) the same factors will continue to raise default
rates, causing earnings problems and debt downgrades among banks and financial companies, 5) earnings shortfalls will also lead to continued job cutbacks, with the unemployment
rate rising to at least 5.5 % (indeed, once the unemployment
rate has advanced
by 0.5 % from its lows, it has never reversed until rising
by least 1.5 % off those lows).
Factors that could cause actual
results to differ include general business and economic conditions and the state of the solar industry; governmental support for the deployment of solar power; future available supplies of high - purity silicon; demand for end - use products
by consumers and inventory levels of such products in the supply chain; changes in demand from significant customers; changes in demand from major markets such as Japan, the U.S., India and China; changes in customer order patterns; changes in product mix; capacity utilization; level of competition; pricing pressure and declines in average selling prices; delays in new product introduction; delays in utility - scale project approval process; delays in utility - scale project construction; cancelation of utility - scale feed - in - tariff contracts in Japan; continued success in technological innovations and delivery of products with the features customers demand; shortage in supply of materials or capacity requirements; availability of financing; exchange
rate fluctuations; litigation and other risks as described in the Company's SEC filings, including its annual report on Form 20 - F filed on April 27, 2017.
As a
result, retail sales taxes raise the Canadian METR [marginal effective tax
rate]
by approximately 2.5 percentage points, compared to the 9 percentage points that would prevail in the absence of any exemptions.
Although most scenarios
resulted in portfolio success (the portfolio was able to sustain a 4 percent withdrawal
rate over the 35 - year period), we were surprised
by the proportion of scenarios that
resulted in portfolio failure — 18 of the 100 scenarios.
What is more, when large countries, like Japan in the 1980s or China in the 2000s, try to generate very rapid domestic growth
by repressing domestic interest
rates and undervaluing the currency, because of the
resulting surge in their reserve accumulation, their soaring current account deficit must be balanced
by a soaring US current account surplus, which exacerbates the Triffin Dilemma significantly.
By doing so slowly, they can monitor the impact of their campaign, and I suspect that, as far as they can see, it looks to be going well — they're «normalizing» the
rate, yet, May's
results aside, not much dampening the pace of output or job growth.
Another Study Shows How Featured Snippets Steal Significant Traffic from the Top Organic
Result A new study by Ahrefs found that when a featured snippet is present on a Google page, the first organic result received a significant drop in click - through - rate
Result A new study
by Ahrefs found that when a featured snippet is present on a Google page, the first organic
result received a significant drop in click - through - rate
result received a significant drop in click - through -
rate (CTR).
However,
by September 2013, the IMF had done a 360 - degree turn and had the U.S leading a global recovery (albeit not very strongly) and the emerging market economies struggling with rising interest
rates, capital flight and falling exchange
rates,
resulting from the possibility of a tapering of Federal Reserve Board monetary stimulus.